Enanta Pharmaceuticals
ENTA
#8491
Rank
S$0.36 B
Marketcap
S$12.43
Share price
-9.61%
Change (1 day)
-25.36%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : S$0.25 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are S$0.25 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-09-30S$0.27 B-12.49%
2024-09-30S$0.31 B-5.05%
2023-09-30S$0.33 B332.14%
2022-09-30S$77.62 M45.19%
2021-09-30S$53.46 M28.23%
2020-09-30S$41.69 M10.35%
2019-09-30S$37.78 M34.49%
2018-09-30S$28.09 M-17.18%
2017-09-30S$33.92 M119.26%
2016-09-30S$15.47 M10.28%
2015-09-30S$14.03 M62.64%
2014-09-30S$8.62 M5.65%
2013-09-30S$8.16 M-19.3%
2012-09-30S$10.11 M88.07%
2011-09-30S$5.38 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$149.35 B 59,090.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$102.56 B 40,545.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
S$181.71 B 71,913.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$9.24 B 3,564.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$113.17 B 44,750.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$84.24 B 33,284.75%๐Ÿ‡บ๐Ÿ‡ธ USA